In CAH, the absence of a critical enzyme allows a 46,XX fetus to produce androgens, resulting in ambiguous external genitals. A CAH individual may have an oversized clitoris and fused labia.

CAH is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 14.78; value investors should ...

West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp. Regional pharmacy chain operator Giant Eagle ...

Thankfully, there’s a perfect answer for that. The popular card game company CAH has filed a lawsuit against SpaceX and in turn, Elon Musk, as they have reportedly been using CAH’s lot in ...

The most recent trading session ended with Cardinal Health (CAH) standing at $110.33, reflecting a -0.17% shift from the previouse trading day's closing. The stock exceeded the S&P 500 ...

Cardinal Health Inc. (NYSE: CAH) is well-poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment. However, inflationary ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

CAH is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. CAH has a Momentum Style Score of B, and shares are up 0.6% over the past ...

CAH boasts a Momentum Style Score of B and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. Shares of Cardinal Health has seen some interesting price action recently; the stock is down 0.6% ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...